Hyperplasia of pericytes is one of the main characteristics of microvascular architecture in malignant glioma

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Sun, Huiqin ^a   Guo, Deyu ^a   Su, Yongping ^a   Yu, Dongmei ^a   Wang, Qingliang ^a   Wang, Tao ^a   Zhou, Qing ^a   Ran, Xinze ^a   Zou, Zhongmin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; KI 67 ANTIGEN; PLATELET DERIVED GROWTH FACTOR B;

ADULT; ANGIOGENESIS; ARTICLE; CD34 SELECTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MICROVASCULAR NUMBER DENSITY; MICROVASCULAR PERICYTE AREA DENSITY; MICROVASCULAR PERICYTE NUMBER DENSITY; MICROVASCULATURE; PERICYTE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; UPREGULATION; AGED; BLOOD VESSEL; BRAIN TUMOR; CANCER STAGING; FEMALE; GENETICS; GLIOMA; MALE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ADULT; AGED; BLOOD VESSELS; BRAIN NEOPLASMS; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; GLIOMA; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES;

EID: 84918539454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114246     Document Type: Article

References (38)

1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
2. Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358: 2039-2049.
3. Ahmed F, Steele JC, Herbert JM, Steven NM, Bicknell R (2008) Tumor stroma as a target in cancer. Curr Cancer Drug Targets 8: 447-453.
4. Folkman J (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175: 409-416.
5. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286.
6. Bian XW, Chen JH, Jiang XF, Bai JS, Wang QL, et al. (2004) Angiogenesis as an immunopharmacologic target in inflammation and cancer. Int Immunopharmacol 4: 1537-1547.
7. Hida K, Ohga N, Akiyama K, Maishi N, Hida Y (2013) Heterogeneity of tumor endothelial cells. Cancer Sci 104: 1391-1395.
8. Kalinski T, Sel S, Kouznetsova I, Ropke M, Roessner A (2009) Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors. Pathol Res Pract 205: 339-345.
9. Junttila MR, de Sauvage FJ (2013) Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501: 346-354.
10. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410.
11. Bian XW, Wang QL, Xiao HL, Wang JM (2006) Tumor microvascular architecture phenotype (T-MAP) as a new concept for studies of angiogenesis and oncology. J Neurooncol 80: 211-213.
12. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, et al. (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8: 610-622.
13. Jouanneau E (2008) Angiogenesis and gliomas: current issues and development of surrogate markers. Neurosurgery 62: 31-50; discussion 50-32.
14. Tate MC, Aghi MK (2009) Biology of angiogenesis and invasion in glioma. Neurotherapeutics 6: 447-457.
15. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97: 512-523.
16. Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7: 452-464.
17. Virgintino D, Ozerdem U, Girolamo F, Roncali L, Stallcup WB, et al. (2008) Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy. J Vasc Res 45: 129-131.
18. Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, et al. (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153: 139-152.
19. Liu AY, Ouyang G (2013) Tumor angiogenesis: a new source of pericytes. Curr Biol 23: R565-568.
20. Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, et al. (1995) Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol 54: 304-310.
21. Takeuchi H, Hashimoto N, Kitai R, Kubota T, Kikuta K (2010) Proliferation of vascular smooth muscle cells in glioblastoma multiforme. J Neurosurg 113: 218-224.
22. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
23. Weidner N (1998) Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184: 119-122.
24. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, et al. (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60: 1388-1393.
25. Zhong C, Duan L, Wang K, Xu Z, Ge Y, et al. (2013) Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease. J Gastroenterol 48: 601-610.
26. Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JM, et al. (2005) A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Brain Res Protoc 16: 58-64.
27. Wang CJ, Zhou ZG, Holmqvist A, Zhang H, Li Y, et al. (2009) Survivin expression quantified by Image Pro-Plus compared with visual assessment. Appl Immunohistochem Mol Morphol 17: 530-535.
28. Friedrichs K, Gluba S, Eidtmann H, Jonat W (1993) Overexpression of p53 and prognosis in breast cancer. Cancer 72: 3641-3647.
29. Mountzios G, Kostopoulos I, Kotoula V, Sfakianaki I, Fountzilas E, et al. (2013) Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer. PLoS One 8: e54048.
30. Aird WC (2009) Molecular heterogeneity of tumor endothelium. Cell Tissue Res 335: 271-281.
31. Egeblad M, Nakasone ES, Werb Z (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18: 884-901.
32. Nagy JA, Dvorak HF (2012) Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets. Clin Exp Metastasis 29: 657-662.
33. Lebelt A, Dzieciol J, Guzinska-Ustymowicz K, Lemancewicz D, Zimnoch L, et al. (2008) Angiogenesis in gliomas. Folia Histochem Cytobiol 46: 69-72.
34. Cao Y, Zhang ZL, Zhou M, Elson P, Rini B, et al. (2013) Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Cancer 119: 313-324.
35. Ribatti D, Nico B, Crivellato E (2011) The role of pericytes in angiogenesis. Int J Dev Biol 55: 261-268.
36. Gaengel K, Genove G, Armulik A, Betsholtz C (2009) Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29: 630-638.
37. Shih AH, Holland EC (2006) Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 232: 139-147.
38. Nolte I, Przibylla H, Bostel T, Groden C, Brockmann MA (2008) Tumor-platelet interactions: glioblastoma growth is accompanied by increasing platelet counts. Clin Neurol Neurosurg 110: 339-342.